Five-chlorodeoxycytidine and biomodulators of its metabolism result in fifty to eighty percent cures of advanced EMT-6 tumors when used with fractionated radiation

https://doi.org/10.1016/0360-3016(94)00596-DGet rights and content
Under a Creative Commons license
open archive

Keywords

5-Chloro-2′-deoxycytidine (CldC)
Tetrahydrouridine (H4U)
N-(Phosphonacetyl)-L-aspartate (PALA)
5-Fluoro-2′-deoxycytidine (FdC)
EMT-6 rodent mammary adenocarcinoma
Radiosensitization

Cited by (0)